2005
DOI: 10.1016/j.ejphar.2004.11.011
|View full text |Cite
|
Sign up to set email alerts
|

Effects of SEA0400, a Na+/Ca2+ exchange inhibitor, on ventricular arrhythmias in the in vivo dogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
25
1
1

Year Published

2006
2006
2023
2023

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(29 citation statements)
references
References 25 publications
2
25
1
1
Order By: Relevance
“…This provides pharmacological evidence that NCX plays a crucial role in ouabain-induced arrhythmogenesis. It was also reported that SEA0400 attenuated ouabain-induced arrhythmia in a canine in vivo model (18) and in isolated Purkinje fibers (24). The effect of SEA0400 on other types of arrhythmia has also been investigated.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This provides pharmacological evidence that NCX plays a crucial role in ouabain-induced arrhythmogenesis. It was also reported that SEA0400 attenuated ouabain-induced arrhythmia in a canine in vivo model (18) and in isolated Purkinje fibers (24). The effect of SEA0400 on other types of arrhythmia has also been investigated.…”
Section: Discussionmentioning
confidence: 99%
“…Concerning the action of cardiac glycosides, inhibition by SEA0400 of digitalis-induced arrhythmias in canine models was reported (18), but the mechanisms of cardiac glycoside-induced inotropy and arrhythmogenesis has not been examined in the isolated working myocardium with this selective inhibitor. The present study was performed to obtain pharmacological evidence for the involvement of NCX in cardiac glycosideinduced inotropy and arrhythmogenesis.…”
Section: Introductionmentioning
confidence: 99%
“…SN-6 protects against cardiac ischemia / reperfusion injury and also acts as an oxygen radical scavenger (73). On the other hand, SEA0400 and KB-R7943 do not reduce significantly mortality from ischemia / reperfusion injury, ouabain-induced arrhythmia, and coronary reperfusion-induced arrhythmia (71,74). Further studies are necessary to establish NCX inhibitors as therapeutic agents.…”
Section: Discussionmentioning
confidence: 99%
“…Experimental data on the antiarrhythmic effects of SEA0400 are sparse and contradictory, although mostly positive [47][48][49][50], while similar data for ORM-10103 have become available only very recently [41,51,52]. SEA0400 has a moderate inhibitory effect on the L-type Ca 2+ channels [40], while ORM-10103 has a minor effect on IKr; neither of these pleiotropic effects could substantially modulate the observed antiarrhythmic efficacy of the NCX inhibition.…”
Section: Regional Ischaemiamentioning
confidence: 99%
“…Recent experimental data demonstrate that these pathological processes are tightly linked to the abnormal activities of two vital sarcolemmal ion transporters, the Na [57,58]. In the majority of related experimental studies, the inhibition of one of these transporters could reduce the incidence and/or severity of ventricular arrhythmias [32,33,49,59,60]. Therefore, restoring the normal levels of their activities via pharmacological intervention is generally considered a highly feasible therapeutic strategy to prevent, or at least substantially reduce, reperfusioninduced arrhythmogenesis.…”
Section: Rationalementioning
confidence: 99%